Immunome, Inc.

IMNM · Healthcare · Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-dr…

Immunome, Inc. (IMNM), in the Healthcare sector, has 20 disclosed filings on Paydirt over the trailing twelve months from 9 corporate insiders: 7 purchases and 14 sales. Filers took a median of 3 days from execution to disclosure, and the most recent trade was executed Sep 11 and filed Sep 15. The most active filer was Clay B Siegall with 7 filings.

Add to watchlist

Filings, ttm

7 buys · 14 sells

Traders, ttm

9 insiders

Volume, ttmiDollar value disclosed in the window

$29.6M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 11

Filed Sep 15

ADViAverage daily dollar volume

$31.5M

market data

Share price · 12M

$25.07 (+156.6%)

Adjusted for splits and dividends.

Volume by month

Buys $5.8M Sells $27.4M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Clay B Siegall President and CEO 7 filings IB

Isaac Barchas Director 5 filings RL

Robert Lechleider Chief Medical Officer 3 filings PT

Philip Tsai Chief Technology Officer 3 filings JB

Jean Jacques Bienaime Director 2 filings JH

Jack Higgins Chief Scientific Officer 2 filings MR

Max Rosett Chief Financial Officer 2 filings KH

Kinney Horn CHIEF BUSINESS OFFICER 1 filing

Recent filings

Jack HigginsSALE Chief Scientific Officer $334K
13,200 sh × $25.32
Exec Sep 11
Filed Sep 15 · 4:30 PM ET Isaac BarchasSALE Director $2.2M
83,464 sh across 3 lots
Exec Aug 10
Filed Aug 12 · 5:47 PM ET Isaac BarchasSALE Director $940K
36,088 sh across 2 lots
Exec Aug 6
Filed Aug 10 · 4:10 PM ET Kinney HornSALE CHIEF BUSINESS OFFICER $2.3M
90,616 sh × $25.09
Exec Aug 4
Filed Aug 6 · 6:30 PM ET Isaac BarchasSALE Director $2.4M
100,000 sh across 2 lots
Exec Jul 6
Filed Jul 7 · 7:02 PM ET Robert LechleiderSALE Chief Medical Officer $1.2M
55,000 sh across 3 lots
Exec Jul 2
Filed Jul 7 · 5:42 PM ET Isaac BarchasSALE Director $4.4M
201,050 sh across 3 lots
Exec Jun 30
Filed Jul 2 · 8:31 PM ET Robert LechleiderSALE Chief Medical Officer $1.1M
55,000 sh across 2 lots
Exec Jun 25
Filed Jun 29 · 5:30 PM ET Max RosettSALE Chief Financial Officer $1.1M
60,000 sh × $18.23
Exec Jun 15
Filed Jun 17 · 5:30 PM ET Jean Jacques BienaimePURCHASE Director $117K
6,000 sh × $19.48
Exec Jun 5
Filed Jun 9 · 5:40 PM ET Jean Jacques BienaimeSALE Director $194K
10,000 sh × $19.41
Exec Jun 5
Filed Jun 9 · 5:30 PM ET Jean Jacques BienaimePURCHASE Director $104K
5,000 sh × $20.70
Exec May 15
Filed May 19 · 7:56 AM ET Max RosettSALE Chief Financial Officer $1.4M
63,656 sh × $21.91
Exec Apr 2
Filed Apr 3 · 5:30 PM ET Jack HigginsSALE Chief Scientific Officer $204K
9,438 sh × $21.64
Exec Apr 2
Filed Apr 3 · 5:30 PM ET Clay B SiegallPURCHASE President and CEO $501K
25,450 sh × $19.67
Exec Mar 27
Filed Mar 31 · 7:11 AM ET Philip WagenheimSALE Director $1.3M
65,000 sh across 2 lots
Exec Mar 20
Filed Mar 23 · 5:30 PM ET Clay B SiegallPURCHASE President and CEO $100K
4,729 sh × $21.15
Exec Dec 30 2025
Filed Dec 30 2025 · 6:47 PM ET Isaac BarchasSALE Director $8.3M
383,200 sh across 2 lots
Exec Dec 22 2025
Filed Dec 23 2025 · 5:30 PM ET Clay B SiegallPURCHASE President and CEO $149K
7,278 sh × $20.48
Exec Dec 19 2025
Filed Dec 22 2025 · 7:38 AM ET Philip TsaiPURCHASE Chief Technical Officer $205K
10,000 sh × $20.49
Exec Dec 19 2025
Filed Dec 22 2025 · 7:32 AM ET Clay B SiegallPURCHASE President and CEO $1000K
46,511 sh × $21.50
Exec Dec 18 2025
Filed Dec 18 2025 · 5:03 PM ET Clay B SiegallPURCHASE President and CEO $999K
137,100 sh × $7.29
Exec Mar 26 2025
Filed Mar 26 2025 · 5:30 PM ET Philip TsaiPURCHASE Chief Technology Officer $104K
12,300 sh × $8.42
Exec Mar 24 2025
Filed Mar 25 2025 · 5:30 PM ET Clay B SiegallPURCHASE President and CEO $1.2M
150,000 sh × $7.75
Exec Jan 31 2025
Filed Feb 3 2025 · 5:30 PM ET Philip TsaiPURCHASE Chief Technology Officer $198K
21,000 sh × $9.43
Exec Nov 21 2024
Filed Nov 25 2024 · 5:30 PM ET